Publication

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH

Scientific Reports 9(1):9046, 2019

Roth JD, Veidal SS, Fensholdt LKD, Rigbolt KTG, Papazyan R, Nielsen JC, Feigh M, Vrang N, Young M, Jelsing J, Adorini L, Hansen HH

Share this page

Resource Library

Related resources

Characterization of dietary intervention in the non-obese CDAA-HFD mouse model of advanced NASH with progressive fibrosis

Metabolic, biochemical and histological effects of semaglutide in a CDAA-HFD-induced non-obese and biopsy-confirmed rat model of NASH with progressive fibrosis and tumor development

Bariatric surgery in patients with non-alcoholic fatty liver disease – from pathophysiology to clinical effects

Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650